Quote For Geron Corp GERN.O
sector: Healthcare ·
industry: Biotechnology ·
As of
27 Nov 2009
5.33USD
$5.33
27 Nov 2009
-2.38%
$5.46
$5.33
658,718
$5.43
$5.26
$9.24
$3.00
0.91
1,046,561
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Barkas, Alexander |
Chairman of the Board |
-- |
| Okarma, Thomas |
President, Chief Executive Officer, Director |
3,103,530 |
| Greenwood, David |
Chief Financial Officer, Executive Vice President, Treasurer, Secretary |
1,880,660 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$488.38 |
| Shares Outstanding (Mil.) |
91.63 |
| Float (Mil.) |
89.20 |
| |
| Dividend Information |
| Yield % |
-99,999.99 |
| Annual Dividend ($ USD) |
0.00 |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
21.82 |
| Current Ratio |
19.73 |
| LT Debt/Equity |
0.00 |
| Total Debt/Equity |
0.73 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
-- |
| Price/Sales(TTM) |
293.32 |
| Price/Book(TTM) |
2.67 |
| Price/Cash Flow(TTM) |
-- |
| |
|
| Per Share Data |
| Earnings(TTM) |
$-0.82 |
| Sales(TTM) |
$0.02 |
| Book Value(MRQ) |
$2.00 |
| Cash Flow(TTM) |
$-0.80 |
| Cash(MRQ) |
$1.95 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
-38.43 |
| Return on Assets(TTM) |
-36.56 |
| Return on Investment(TTM) |
-38.37 |
| |
|
| Margins |
| Gross Margin(TTM) % |
-- |
| Operating Margin(TTM) % |
-4,178.08 |
| Profit Margin(TTM) % |
-4,181.08 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives